239.5

+4.54%↑

BAS

50.94

-2.75%↓

REP

23.49

-4.74%↓

337.8

+5.96%↑

EXE.US

107.11

-5.02%↓

239.5

+4.54%↑

BAS

50.94

-2.75%↓

REP

23.49

-4.74%↓

337.8

+5.96%↑

EXE.US

107.11

-5.02%↓

239.5

+4.54%↑

BAS

50.94

-2.75%↓

REP

23.49

-4.74%↓

337.8

+5.96%↑

EXE.US

107.11

-5.02%↓

239.5

+4.54%↑

BAS

50.94

-2.75%↓

REP

23.49

-4.74%↓

337.8

+5.96%↑

EXE.US

107.11

-5.02%↓

239.5

+4.54%↑

BAS

50.94

-2.75%↓

REP

23.49

-4.74%↓

337.8

+5.96%↑

EXE.US

107.11

-5.02%↓

Kodu・Aktsiate loetelu・H&R GmbH & Co KGaA

2
H&R GmbH & Co KGaA

Suletud

3.93 -0.25

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

3.75

Max

3.94

Põhinäitajad
By Trading Economics
Sissetulek	970K -662K
Müük	3.3M 311M
Dividenditootlus	2.01
Kasumimarginaal	-0.213

Soovitused
By TipRanks
Soovitused	Müü
12 kuu keskmine prognoos	-2.2% downside

Dividendid
By Dow Jones
Dividenditootlus Sektori keskmine	2.01% 3.17%
Järgmine tulemuste avaldamine	15. mai 2026

Turustatistika
By TradingEconomics
Turukapital	260M
Eelmine avamishind	4.18
Eelmine sulgemishind	3.93

Tehniline skoor

By Trading Central

Kindlus

Bearish Evidence

3.94 / 4 Toetus ja vastupanu

H&R GmbH & Co KGaA Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

31. märts 2026, 23:31 UTC

Kuumad aktsiad

Stocks to Watch: Nike, RH, NCino

31. märts 2026, 22:35 UTC

Tulu

Nike Guides for Sales Declines Ahead as Turnaround Plan Hits Snags -- 2nd Update

1. apr 2026, 00:00 UTC

Omandamised, ülevõtmised, äriostud

The Year Is Off to the Strongest Start for Big Deals Ever -- WSJ

31. märts 2026, 23:50 UTC

Omandamised, ülevõtmised, äriostud

Nxera Pharma: Partner Centessa Pharmaceuticals to Be Acquired by Lilly >LLY 4565.TO

31. märts 2026, 23:43 UTC

Market Talk

Nikkei May Rise on Hopes for Iran War Ending Soon -- Market Talk

31. märts 2026, 23:33 UTC

Market Talk

Uudisväärsed sündmused

Gold Edges Higher on Signs of De-Escalating Middle East Tensions -- Market Talk

31. märts 2026, 23:21 UTC

Tulu

Nike Stock Slides on Tariff Impact Despite Earnings Beat; Turnaround Continues -- Barrons.com

31. märts 2026, 23:14 UTC

Market Talk

Tulu

Nike CEO Says Turnaround is Taking Longer Than He'd Like -- Market Talk

31. märts 2026, 23:12 UTC

Market Talk

Aurelia's Cash Flow Strength Highlighted by New Financing Deal -- Market Talk

31. märts 2026, 22:36 UTC

Tulu

China Vanke 2025 Loss Widens >000002.SZ

31. märts 2026, 22:36 UTC

Tulu

China Vanke: Increase in Inventory Impariment Provision Among Factors Weighing On Results>000002.SZ

31. märts 2026, 22:36 UTC

Tulu

China Vanke 2025 Loss CNY88.56B Vs. Loss CNY49.48B >000002.SZ

31. märts 2026, 22:36 UTC

Tulu

China Vanke: Will Take Time to Resolve Issues Caused by High Debt Levels>000002.SZ

31. märts 2026, 22:36 UTC

Tulu

China Vanke 2025 Rev CNY233.43B Vs. CNY343.18B >000002.SZ

31. märts 2026, 21:46 UTC

Omandamised, ülevõtmised, äriostud

Big Drug Companies Hunting for Deals Are Lowering Their Sights -- WSJ

31. märts 2026, 21:36 UTC

Market Talk

West African Resources's Costs Higher Than Bull Expected -- Market Talk

31. märts 2026, 21:35 UTC

Tulu

Nike Expects China Sales Down 20% in 4Q, CFO Says

31. märts 2026, 21:35 UTC

Tulu

Nike Expects Modest Growth in North America, Offset by Declines in China, Converse Brand in 4Q, CFO Says

31. märts 2026, 21:35 UTC

Tulu

Nike Forecasts 4Q Sales Down 2% to 4%, CFO Says

31. märts 2026, 21:33 UTC

Omandamised, ülevõtmised, äriostud

Biotechs Are a Healthy Growth Bet Thanks to M&A and New Drugs -- Barrons.com

31. märts 2026, 21:33 UTC

Tulu

Nike Expects Sales Down Low-Single Digits From Now Through End of Calendar Year, CFO Says

31. märts 2026, 21:32 UTC

Tulu

Nike Expects 1Q to Be Final Quarter Where Tariffs Continue to Be Year-Over-Year Headwind to Margins, CFO Says

31. märts 2026, 21:28 UTC

Tulu

Nike Expects to End 4Q With Elevated Inventory, CFO Says

31. märts 2026, 21:26 UTC

Tulu

Nike Increasingly Confident It Will Return to Balanced Growth in North America in Direct, Wholesale Channels, CFO Says

31. märts 2026, 21:25 UTC

Tulu

Nike Expects Supply-Chain Changes to Pay Off Starting in Fiscal 2027, CFO Says

31. märts 2026, 21:24 UTC

Market Talk

Tulu

Nike: Turnaround Plan Progressing at Different Rates -- Market Talk

31. märts 2026, 21:22 UTC

Tulu

Nike CFO Expects Football Training and Basketball Will Return to Growth Over Next Few Quarters

31. märts 2026, 21:22 UTC

Tulu

Nike's Sportswear Business Declined Low-Double Digits in 3Q, CFO Says

31. märts 2026, 21:21 UTC

Tulu

Nike's Digital Channel Still Too Promotional, CFO Says

31. märts 2026, 21:20 UTC

Tulu

Nike CEO: Converse Remains Important to Portfolio

Võrdlus sarnastega

Hinnamuutus

H&R GmbH & Co KGaA Prognoos

Hinnasiht

By TipRanks

-2.2% langus

12 kuu keskmine prognoos

Keskmine 4 EUR -2.2%

Kõrge 4 EUR

Madal 4 EUR

Põhineb 1 Wall Streeti analüütiku instrumendi H&R GmbH & Co KGaA 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Müü

1 ratings

Osta

Hoia

Müü

Põhineb 1 analüütiku instrumendi H&R GmbH & Co KGaA aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

3.94 / 4Toetus ja vastupanu

Recent bearish events outweigh bullish events.

Bullish events outweigh bearish events.

All events are bullish.

Finantsandmed

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

Ärikasum

Ettevõttest H&R GmbH & Co KGaA

H&R GmbH & Co. KGaA

Muud aktsiad sektorist

Schneider Electric SE

239.5

↑ +4.54%

BAS

BASF SE

50.94

↓-2.75%

REP

Repsol SA

23.49

↓-4.74%

Dassault Aviation SA.

337.8

↑ +5.96%

EXE.US

Expand Energy Corp

107.11

↓-5.02%

2 H&R GmbH & Co KGaA

Ülevaade

Aktsiahinna muutus

Põhinäitajad

Soovitused

Dividendid

Turustatistika

Tehniline skoor

H&R GmbH & Co KGaA Graafik

Seotud uudised

Võrdlus sarnastega

H&R GmbH & Co KGaA Prognoos

Hinnasiht

Hinnangu Konsensus

Tehniline skoor

Finantsandmed

Ettevõttest H&R GmbH & Co KGaA

Muud aktsiad sektorist

2
H&R GmbH & Co KGaA